trending Market Intelligence /marketintelligence/en/news-insights/trending/HaZiTdL6qK8cEz8KFv1MlQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Report: 5 PE firms submit 1st-round bids for CapVest's Curium Pharma

Street Talk - Ep. 64: Coronavirus jumpstarts digital adoption

Street Talk Podcast

Street Talk - Ep. 63: Deal talks continue amid bank M&A freeze, setting up for strong Q4

Street Talk Podcast

Street Talk - Ep. 62: 'Brutal' outlook for oil demand offers banks in oil patch no relief

Amid Q1 APAC Fintech Funding Slump, Payment Companies Drove Investments

Report: 5 PE firms submit 1st-round bids for CapVest's Curium Pharma

CapVest Partners LLP received initial bids for Paris-based Curium SAS from private equity firms CVC Capital Partners Ltd., Bain Capital LP, Clayton Dubilier & Rice LLC, Nordic Capital and PAI Partners, Bloomberg News reported, citing people familiar with the matter.

CapVest initiated a bidding process for the sale of Curium in November 2019. The nuclear medicine materials business is expected to sell for at least $3 billion, according to the people, who added that the next round of bids are expected in February.

Representatives for CapVest, CVC, Bain, Nordic Capital and PAI declined to comment, while Clayton Dubilier & Rice did not immediately respond to Bloomberg's request for comment.

Curium manufactures medical imaging supplies and provides materials used in nuclear medicine to help diagnose cancer as well as heart, brain and bone diseases.